Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Recurrent mutations of BRCA1, BRCA2 and PALB2 in the population of breast and ovarian cancer patients in Southern Poland.

Wojcik P, Jasiowka M, Strycharz E, Sobol M, Hodorowicz-Zaniewska D, Skotnicki P, Byrski T, Blecharz P, Marczyk E, Cedrych I, Jakubowicz J, LubiƄski J, Sopik V, Narod S, Pierzchalski P.

Hered Cancer Clin Pract. 2016 Feb 3;14:5. doi: 10.1186/s13053-016-0046-5. eCollection 2016.

2.

Application of next-generation sequencing in clinical oncology to advance personalized treatment of cancer.

Guan YF, Li GR, Wang RJ, Yi YT, Yang L, Jiang D, Zhang XP, Peng Y.

Chin J Cancer. 2012 Oct;31(10):463-70. doi: 10.5732/cjc.012.10216. Epub 2012 Sep 17. Review.

3.

Prevalence of the most frequent BRCA1 mutations in Polish population.

Brozek I, Cybulska C, Ratajska M, Piatkowska M, Kluska A, Balabas A, Dabrowska M, Nowakowska D, Niwinska A, Pamula-Pilat J, Tecza K, Pekala W, Rembowska J, Nowicka K, Mosor M, Januszkiewicz-Lewandowska D, Rachtan J, Grzybowska E, Nowak J, Steffen J, Limon J.

J Appl Genet. 2011 Aug;52(3):325-30. doi: 10.1007/s13353-011-0040-6. Epub 2011 Apr 19.

4.

Age and Geographical Distribution in Families with BRCA1/BRCA2 Mutations in the Slovak Republic.

Ciernikova S, Tomka M, Kovac M, Stevurkova V, Zajac V.

Hered Cancer Clin Pract. 2006 Dec 15;4(1):7-11. doi: 10.1186/1897-4287-4-1-7.

5.

Genetic and preventive services for hereditary breast and ovarian cancer in the czech republic.

Foretova L, Petrakova K, Palacova M, Kalabova R, Navratilova M, Lukesova M, Vasickova P, Machackova E, Kleibl Z, Pohlreich P.

Hered Cancer Clin Pract. 2006 Nov 15;4(1):3-6. doi: 10.1186/1897-4287-4-1-3.

6.

Selecting for BRCA1 testing using a combination of homogeneous selection criteria and immunohistochemical characteristics of breast cancers.

Miolo G, Canzonieri V, De Giacomi C, Puppa LD, Dolcetti R, Lombardi D, Perin T, Scalone S, Veronesi A, Viel A.

BMC Cancer. 2009 Oct 10;9:360. doi: 10.1186/1471-2407-9-360.

7.

High occurrence of BRCA1 intragenic rearrangements in hereditary breast and ovarian cancer syndrome in the Czech Republic.

Vasickova P, Machackova E, Lukesova M, Damborsky J, Horky O, Pavlu H, Kuklova J, Kosinova V, Navratilova M, Foretova L.

BMC Med Genet. 2007 Jun 11;8:32.

8.

Ashkenazi Jews and breast cancer: the consequences of linking ethnic identity to genetic disease.

Brandt-Rauf SI, Raveis VH, Drummond NF, Conte JA, Rothman SM.

Am J Public Health. 2006 Nov;96(11):1979-88. Epub 2006 Oct 3.

9.

High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area.

Pohlreich P, Zikan M, Stribrna J, Kleibl Z, Janatova M, Kotlas J, Zidovska J, Novotny J, Petruzelka L, Szabo C, Matous B.

Breast Cancer Res. 2005;7(5):R728-36. Epub 2005 Jul 19.

Items per page

Supplemental Content

Write to the Help Desk